MRSN
Mersana Therapeutics, Inc. · HEALTHCARE
Director and 10% owner David M Mott bought $15.0M of Mersana Therapeutics, Inc.
Bought$15,000,000
$4.00Price
3,750,000Shares
+46%Stake
What MRSN did for a copier
Prices for MRSN after this filing aren't in yet.
David M Mott's record
9 other buys with 3 months of prices since 2016: on average +19.6% against the S&P 500, and 7 of 9 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Mar 5. Filed Wed, Mar 6, 11:39 AM ET, during the session. Not investment advice.